Comparison of ELISA and HPLC-MS methods for the determination of exenatide in biological and biotechnology-based formulation matrices

The development of biotechnology-based active pharmaceutical ingredients, such as GLP-1 analogs, brought changes in type 2 diabetes treatment options. For better therapeutic efficiency, these active pharmaceutical ingredients require appropriate administration, without the development of adverse eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinho, A.R., Fortuna, A., Falcão, A., Santos, A.C., Seiça, R., Estevens, C., Veiga, F., Ribeiro, A.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Xi'an Jiaotong University 2019
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598173/
https://www.ncbi.nlm.nih.gov/pubmed/31297291
http://dx.doi.org/10.1016/j.jpha.2019.02.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598173/
https://www.ncbi.nlm.nih.gov/pubmed/31297291
http://dx.doi.org/10.1016/j.jpha.2019.02.001

Ejemplares similares